GGrantIndex
← Leaderboards

Tasha E. Fingerlin

University Of Colorado Denver

$10,967,602
Attributed
$16,951,143
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.2M · FY201322
$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$16,951,143 · 7

By mechanism

R01$13,971,005 · 3
P01$1,997,861 · 1
R21$382,278 · 1
R43$300,000 · 1
R41$299,999 · 1

Top collaborators

Most similar at University Of Colorado Denver

Same institution · by research overlap

Others in their field

Top investigators on “Base

Research focus

BasePhenotypeComplexSamplingGeneticVariantDiagnosisResearch PersonnelGenetic VariantLeadFutureDesignCostClinical DataResearch DesignGene ExpressionGenesMultidisciplinaryData IntegrationData SetPathway InteractionsClinical PhenotypeLungBiometry

Grant awards (24)

Novel integrative approaches for disease phenotyping, utilizing radiomics in Sarcoidosis$633,593
R01 · FY2022 · HL · contact PI
A comprehensive next generation sequencing diagnostic tool for lung infection among hospitalized patients$300,000
R43 · FY2022 · AI · contact PI
Novel integrative approaches for disease phenotyping, utilizing radiomics in Sarcoidosis$628,515
R01 · FY2021 · HL · contact PI
Biostatistics, Bioinformatics and Environmental Sampling Core$400,544
P01 · FY2021 · HL · contact PI
Novel integrative approaches for disease phenotyping, utilizing radiomics in Sarcoidosis$649,128
R01 · FY2020 · HL · contact PI
Biostatistics, Bioinformatics and Environmental Sampling Core$398,067
P01 · FY2020 · HL · contact PI
Enabling comprehensive diagnosis of sub-acute infection in chronic respiratory disease via high sensitivity next generation sequencing$299,999
R41 · FY2020 · AI · contact PI
Novel integrative approaches for disease phenotyping, utilizing radiomics in Sarcoidosis$655,027
R01 · FY2019 · HL · contact PI
Biostatistics, Bioinformatics and Environmental Sampling Core$398,067
P01 · FY2019 · HL · contact PI
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)$2,118,048
R01 · FY2018 · HL
Genetic Risk for Granulomatous Interstitial Lung Disease$522,735
R01 · FY2018 · HL · contact PI
Biostatistics, Bioinformatics and Environmental Sampling Core$395,873
P01 · FY2018 · HL · contact PI
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)$2,118,048
R01 · FY2017 · HL
Genetic Risk for Granulomatous Interstitial Lung Disease$642,084
R01 · FY2017 · HL · contact PI
Biostatistics, Bioinformatics and Environmental Sampling Core$405,310
P01 · FY2017 · HL · contact PI
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)$2,118,048
R01 · FY2016 · HL
Genetic Risk for Granulomatous Interstitial Lung Disease$661,205
R01 · FY2016 · HL · contact PI
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)$91,485
R01 · FY2016 · HL
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)$1,799,771
R01 · FY2015 · HL
Genetic Risk for Granulomatous Interstitial Lung Disease$659,738
R01 · FY2014 · HL · contact PI
Integrating linkage information in tests of association for rare variants in ILD$165,885
R21 · FY2014 · HL · contact PI
Integrating linkage information in tests of association for rare variants in ILD$23,633
R21 · FY2014 · HL · contact PI
Genetic Risk for Granulomatous Interstitial Lung Disease$673,580
R01 · FY2013 · HL · contact PI
Integrating linkage information in tests of association for rare variants in ILD$192,760
R21 · FY2013 · HL · contact PI